Juvenil absans epilepsisi, genellikle 9-13 yaşları arasında başlayan ve ağırlıklı olarak absans nöbetlerin görüldüğü ancak takipte motor nöbetlerin de eşlik edebileceği genetik jeneralize epilepsiler grubunda yer alan bir epileptik sendromdur. Çalışmamızda 2010-2022 yılları arasında juvenil absans epilepsi tanısı ile kliniğimizde takip edilen 33 hasta retrospektif olarak değerlendirildi. 13'ü klinik veya elektrofizyolojik bilgilerinin yetersiz olması, izlem sırasında başka bir epileptik sendrom tanısı alması nedeniyle çalışma dışı bırakıldı. Değerlendirmeye alınan 20 hastanın yaş ortalaması 16.8 idi; Ortalama nöbet başlangıç yaşı 10.6 yıldı. Tüm hastalarda günde bir defadan fazla görülmeyen absans nöbetleri, %40'ında ek jeneralize tonik-klonik nöbetler ve %20'sinde elektroensefalografide jeneralize deşarjlara ek olarak fokal elektroensefalografik anormallikler vardı. Tedavisi sonlandırılan 5 hastanın 3'ünde nöbetler tekrarladı. Halihazırda hastaların %85'inin valproik asit ile tedaviye devam ettiği ve monoterapinin yeterli olduğu bulundu. Elektrofizyolojik olarak tanı anında jeneralize deşarjlar varken, takipte fokal bulgular ortaya çıkma eğilimindedir; Bunun da uzun dönem takipli hastalarda nöbet nüksünün ve tedavi seçeneklerinin değerlendirilmesinde önemli olduğu bulundu.
Juvenile absence epilepsy is an epileptic syndrome that usually begins between the ages of 9-13 and is classified in the group of genetic generalized epilepsies, in which absence seizures are seen mainly but may also be accompanied by motor seizures in the follow-up. In our study, 33 patients who were followed up in our clinic with the diagnosis of juvenile absence epilepsy between 2010-2022 were evaluated retrospectively. Thirteen of them were excluded from the study due to insufficient clinical or electrophysiological knowledge, being diagnosed with another epileptic syndrome during follow-up. The mean age of the 20 patients included in the evaluation was 16.8 years; The mean age of seizure onset was 10.6 years. All patients had absence seizures, which were not seen more often than once a day, 40% had additional generalized tonic-clonic seizures, and 20% had focal electroencephalographic abnormalities in addition to generalized discharges on electroencephalography. Seizures recurred in 3 of 5 patients whose treatment was terminated. It was found that currently 85% of the patients continued treatment with valproic acid and monotherapy was sufficient. While there are generalized discharges at the time of diagnosis electrophysiologically, focal findings tend to occur in the follow-up; This was also found to be important in the evaluation of seizure recurrence and treatment options in patients with long-term follow-up.
Primary Language | English |
---|---|
Subjects | Clinical Sciences |
Journal Section | Original Article |
Authors | |
Early Pub Date | December 31, 2022 |
Publication Date | December 31, 2022 |
Submission Date | October 18, 2022 |
Published in Issue | Year 2022 Volume: 32 Issue: 6 |
Journal of General Medicine is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).